Impact of the COVID-19 Pandemic on Radiotherapy Patients by Age and Residence
DOI:
https://doi.org/10.5457/ams.v53i1.661Keywords:
coronavirus disease 2019, hospital patients, external beam radiotherapy, age group, residency.Abstract
Background/Aim: This epidemiology study aimed to investigate how the COVID-19 pandemic affected the weekly number of external beam radiotherapy (EBRT) fractions concerning patient age and residence distance from our radiotherapy center (RTC). Methods: Twenty-two-month intervals before and after the onset of the COVID-19 pandemic were compared. Results: The average weekly number of fractions from May 2018 to February 2020 was 692.8 (SD 67.6), and from March 2020 to December 2021 was 639.3. (SD 84.7). The weekly number of fractions decreased by 42.4 % in March 2021 and by 67.9 % in April 2020 compared to the same period in 2019. When comparing patients under 70 years of age to those over 70, the decrease was 28.0 % vs. 6.9 %, respectively. According to the Wilcoxon signed-rank test (Z = - 5.2, p = 0.001), the outbreak of the COVID-19 pandemic had a statistically significant impact on the decrease in the weekly number of fractions. The distance between the city of residence and the RTC was not a significant factor but years of life (more than 70) was. Conclusion: During the "waves" of the pandemic, radiation therapy (RT) was not administered to specific groups of cancer patients eligible for it because other medical departments for oncology patients were closed.
Downloads
Published
Issue
Section
License
Copyright transfer
The listed authors warrant that they are the authors and sole owners of the submitted manuscript. The authors also warrant that the work is original; that it has not been previously published in print or electronic format and is not under consideration by another publisher or electronic medium; that it has not been previously transferred, assigned, or otherwise encumbered; and that the authors have full power to grant such rights. With respect to the results of this work, the manuscript of this or substantially similar content will not be submitted to any other journal until the review process in the Acta Medica Salinianana has been officially completed (acceptance or rejection of the manuscript). The paper will not be withdrawn from the review process by the Acta Medica Saliniana Editorial Board until the review process is completed. The authors will comply with the requests of the Acta Medica Saliniana Editors and reviewers to improve the paper for publication. The eventual disagreements will be submitted in a written form; the authors are aware that the disagreement(s) with the Acta Medica Saliniana requests may result in the rejection of the manuscript. The authors hereby grant to the Acta Medica Saliniana the right to edit, revise, abridge, and condense the manuscript. If the manuscript is accepted for publication in the Acta Medica Saliniana, the authors hereby transfer the copyright of the paper to the Acta Medica Saliniana. The authors permit the Acta Medica Saliniana to allow third parties to copy any part of the journal without asking for permission, provided that the reference to the source is given. For papers with more than one author: All other co-authors agree to allow the corresponding author to make decisions regarding prepublication release of the information in the paper to the media, federal agencies, or both.
